Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Total Voting Rights

2 Mar 2020 09:31

RNS Number : 6661E
Indivior PLC
02 March 2020
 

INDIVIOR PLC (THE 'COMPANY') - TOTAL VOTING RIGHTS AND CAPITAL

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at March 1, 2020 the Company's issued share capital consisted of 732,408,332 Ordinary Shares of US$0.10 each. The Company does not hold any shares in Treasury.

 

Therefore, the total number of voting rights in the Company is 732,408,332. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Kathryn Hudson

Company Secretary

 

March 2, 2020

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRUUUKRRKUORRR
Date   Source Headline
3rd May 20227:00 amRNSShare Repurchase Program
28th Apr 20227:00 amRNS1st Quarter Results
27th Apr 20227:00 amRNSAppointment of Independent Non-Executive Director
25th Apr 20225:18 pmRNSCommittee Change
7th Apr 202210:30 amRNSNotice of Q1 Results
1st Apr 202210:05 amRNSTotal Voting Rights
31st Mar 20222:00 pmRNSIndivior to Commence Consultations
30th Mar 20223:16 pmRNSAnnual Report and Accounts and Notice of AGM
16th Mar 20221:04 pmRNSDirector/PDMR Shareholding
15th Mar 20221:00 pmRNSDirector/PDMR Shareholding
15th Mar 20221:00 pmRNSDirector/PDMR Shareholding
8th Mar 20221:56 pmRNSDirector/PDMR Shareholding
2nd Mar 202212:22 pmRNSDirector/PDMR Shareholding
18th Feb 202212:10 pmRNSDirector/PDMR Shareholding
16th Feb 20227:00 amRNSFinal Results
1st Feb 202211:41 amRNSTotal Voting Rights
1st Feb 20229:23 amRNSNotice of Results
28th Jan 20227:00 amRNSBuprenorphine-Fentanyl Interaction Study Results
4th Jan 202210:53 amRNSTotal Voting Rights
29th Dec 20211:00 pmRNSTransaction in Own Shares
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20217:00 amRNSTransaction in Own Shares
22nd Dec 20217:00 amRNSTransaction in Own Shares
21st Dec 20217:00 amRNSTransaction in Own Shares
20th Dec 20217:00 amRNSTransaction in Own Shares
17th Dec 20217:00 amRNSTransaction in Own Shares
16th Dec 20217:00 amRNSTransaction in Own Shares
15th Dec 20213:13 pmRNSBlock Listing Application
15th Dec 20217:00 amRNSTransaction in Own Shares
14th Dec 20217:00 amRNSTransaction in Own Shares
13th Dec 20217:00 amRNSTransaction in Own Shares
10th Dec 20217:00 amRNSTransaction in Own Shares
9th Dec 20217:00 amRNSTransaction in Own Shares
8th Dec 20217:00 amRNSTransaction in Own Shares
7th Dec 20217:00 amRNSTransaction in Own Shares
6th Dec 20217:00 amRNSTransaction in Own Shares
3rd Dec 20217:00 amRNSTransaction in Own Shares
2nd Dec 20217:00 amRNSTransaction in Own Shares
1st Dec 202111:52 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTransaction in Own Shares
30th Nov 20214:05 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSTransaction in Own Shares
29th Nov 20217:00 amRNSTransaction in Own Shares
26th Nov 20217:00 amRNSTransaction in Own Shares
25th Nov 20217:00 amRNSTransaction in Own Shares
24th Nov 20217:00 amRNSTransaction in Own Shares
23rd Nov 20217:00 amRNSTransaction in Own Shares
22nd Nov 20217:00 amRNSTransaction in Own Shares
19th Nov 20217:00 amRNSTransaction in Own Shares
18th Nov 20214:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.